Novavax is close to securing FDA approval for its Covid-19 vaccine yet NVAX stock is down since the end of January. What gives? More
Articles
Avoid General Motors as It Tries to Take on Tesla With Luxury EVs
GM Stock is taking direct aim at Tesla with its electric Hummer and Cadillac, but it's leaving the middle of the market underserved. More
Buy the Dip in UiPath NOW for Huge Gains
The Russia-Ukraine war is causing some headwinds for UiPath. But once it ends, UiPath stock will bounce back in a big way. More
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
If you're looking for the biggest pre-market stock movers for Monday, we've got you covered with a list of gainers and losers for today. More
Ripple Continues to Deliver Real-World Utility and Success
Qatar’s largest financial institution announced it will use Ripple for cross-border real-time payments for customers across 31 countries. More
Even If Matterport Stock Has Found a Floor, a Comeback Will Take Time
The jury's still out whether MTTR stock holds steady, or drops again, in the coming months. But in terms of it making a substantial recovery, expect it to play out over a longer timeframe. More
